:

Samuel Klistorner1, Michael H Barnett2, Chenyu Wang3

  • 1Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia.

概括

随着多发性硬化症 (MS) 的进展,尤其是二次进展性MS (SPMS) 时,状的体积会增加. 这种与炎症和组织损伤相关的扩大可能成为MS的关键生物标志物.